Pacific Biosciences of California, Inc. Increase (Decrease) in Deferred Revenue
Pacific Biosciences of California, Inc. (PACB) reported Increase (Decrease) in Deferred Revenue of $35.06 million for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2013-11-12
- Pacific Biosciences of California, Inc. increase (decrease) in deferred revenue for the quarter ending 2013-09-30 was $35.15M.
- Pacific Biosciences of California, Inc. increase (decrease) in deferred revenue for the quarter ending 2013-06-30 was $326.00K, a 14.39% increase year-over-year.
- Pacific Biosciences of California, Inc. increase (decrease) in deferred revenue for the quarter ending 2013-03-31 was -$423.00K.
- Pacific Biosciences of California, Inc. increase (decrease) in deferred revenue for the quarter ending 2012-12-31 was -$377.00K, a 120.03% decline year-over-year.
- Pacific Biosciences of California, Inc. increase (decrease) in deferred revenue for fiscal 2012 was -$1.67M, a 163.63% decline from fiscal 2011.
- Pacific Biosciences of California, Inc. increase (decrease) in deferred revenue for fiscal 2011 was $2.63M, a 18.32% decline from fiscal 2010.
- Pacific Biosciences of California, Inc. increase (decrease) in deferred revenue for fiscal 2010 was $3.22M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2013-09-30 | $35.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $35.48M derived: sum of 2 quarters · filed 2013-11-12 | $35.06M 10-Q · filed 2013-11-12 | $34.68M derived: sum of 4 quarters · filed 2013-11-12 |
| 2013-06-30 | $326.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$97.00K 10-Q · filed 2013-08-09 | -$474.00K derived: sum of 3 quarters · filed 2013-08-09 | -$1.57M derived: sum of 4 quarters · filed 2013-11-12 |
| 2013-03-31 | -$423.00K 10-Q · filed 2013-05-10 | -$800.00K derived: sum of 2 quarters · filed 2013-05-10 | -$1.89M derived: sum of 3 quarters · filed 2013-11-12 | -$1.61M derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-12-31 | -$377.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$1.47M derived: sum of 2 quarters · filed 2013-11-12 | -$1.19M derived: sum of 3 quarters · filed 2013-11-12 | -$1.67M 10-K · filed 2013-03-15 |
| 2012-09-30 | -$1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$808.00K derived: sum of 2 quarters · filed 2013-11-12 | -$1.30M 10-Q · filed 2013-11-12 | $585.00K derived: sum of 4 quarters · filed 2013-11-12 |
| 2012-06-30 | $285.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$204.00K 10-Q · filed 2013-08-09 | $1.68M derived: sum of 3 quarters · filed 2013-08-09 | $3.27M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-03-31 | -$489.00K 10-Q · filed 2013-05-10 | $1.39M derived: sum of 2 quarters · filed 2013-05-10 | $2.98M derived: sum of 3 quarters · filed 2013-05-10 | $1.01M derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $3.47M derived: sum of 2 quarters · filed 2013-03-15 | $1.50M derived: sum of 3 quarters · filed 2013-03-15 | $2.63M 10-K · filed 2013-03-15 |
| 2011-09-30 | $1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | -$380.00K derived: sum of 2 quarters · filed 2012-11-01 | $749.00K 10-Q · filed 2012-11-01 | |
| 2011-06-30 | -$1.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$840.00K 10-Q · filed 2012-08-07 | ||
| 2011-03-31 | $1.13M 10-Q · filed 2012-05-07 | |||
| 2010-12-31 | $3.22M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |